@elhackernet Absofinglutely... agree with this. However, let me draw your attention to ticker SGMO in the biotech space. They are about to partner a gene therapy for Fabry disease. It affects maybe 1 in 40K people. It's working fantastically, especially compared to the standard of care. Observe the snip from their recent conference call. All I can say to folks is do your own due diligence, but buy buy buy!